Is the positive predictive value of high-grade cytology in predicting high-grade cervical disease falling due to HPV vaccination?
Farhana Sultana, Karen Winch, Marion Saville, Julia ML Brotherton
International Journal of Cancer | WILEY | Published : 2019
JMLB and MS are chief investigators of the NHMRC Centre for Research Excellence in Cervical Cancer Control (APP1135172) from which FS receives salary support. JB and MS are investigators of a trial of primary HPV screening in Australia (Compass) that has received a part funding contribution from Roche Molecular Systems, Ventana Inc. USA. VCSR acknowledges the support of the Victorian Government.